Ethics approval and consent to participate
SECONDARY
This study was a secondary analysis of a cohort study approved by the Clinical Research Review Board of Peking University First Hospital (#2017–1378). Written informed consent was obtained from all subjects and/or their legal guardians. This study was registered in the Chinese Clinical Trial Registry on 10/09/2017 (